SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Actinium Pharmaceuticals, Inc. Commences Screening for the Second Cohort of Patients in the Company's Ongoing Phase I/II Trial in Acute Myeloid Leukemia